Integral Diagnostics Limited
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more
Integral Diagnostics Limited (ITGDF) - Total Assets
Latest total assets as of June 2025: $1.43 Billion USD
Based on the latest financial reports, Integral Diagnostics Limited (ITGDF) holds total assets worth $1.43 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Integral Diagnostics Limited - Total Assets Trend (2019–2025)
This chart illustrates how Integral Diagnostics Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Integral Diagnostics Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Integral Diagnostics Limited's total assets of $1.43 Billion consist of 6.7% current assets and 93.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.7% |
| Accounts Receivable | $30.08 Million | 2.1% |
| Inventory | $2.52 Million | 0.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $59.88 Million | 4.2% |
| Goodwill | $802.50 Million | 56.3% |
Asset Composition Trend (2019–2025)
This chart illustrates how Integral Diagnostics Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Integral Diagnostics Limited's current assets represent 6.7% of total assets in 2025, a decrease from 10.8% in 2019.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, down from 6.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, a decrease from 63.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 56.3% of total assets.
Integral Diagnostics Limited Competitors by Total Assets
Key competitors of Integral Diagnostics Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Integral Diagnostics Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Integral Diagnostics Limited generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Integral Diagnostics Limited generates $ 0.33 in net profit.
Integral Diagnostics Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.68 | 0.87 | 1.92 |
| Quick Ratio | 0.66 | 0.85 | 1.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-45.38 Million | $ -10.86 Million | $ 73.98 Million |
Integral Diagnostics Limited - Advanced Valuation Insights
This section examines the relationship between Integral Diagnostics Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.82 |
| Latest Market Cap to Assets Ratio | 0.26 |
| Asset Growth Rate (YoY) | 91.7% |
| Total Assets | $1.43 Billion |
| Market Capitalization | $372.93 Million USD |
Valuation Analysis
Below Book Valuation: The market values Integral Diagnostics Limited's assets below their book value (0.26 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Integral Diagnostics Limited's assets grew by 91.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Integral Diagnostics Limited (2019–2025)
The table below shows the annual total assets of Integral Diagnostics Limited from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $1.43 Billion | +91.66% |
| 2024-06-30 | $744.28 Million | -11.29% |
| 2023-06-30 | $839.01 Million | +7.15% |
| 2022-06-30 | $783.01 Million | +19.56% |
| 2021-06-30 | $654.90 Million | +12.82% |
| 2020-06-30 | $580.47 Million | +84.47% |
| 2019-06-30 | $314.67 Million | -- |